ClinicalTrials.govpublic full text
ACHIEVE: Optimizing the Treatment of Secondary Hyperparathyroidism
secondary hyperparathyroidism, vitamin d, sensipar®, cinacalcet hcl, chronic kidney disease, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 828878
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.